Adam Nopora

发表

Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models

U. Weidle, A. Nopora, Adam Nopora, 2020, Cancer Genomics & Proteomics.

Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical In Vivo Models.

U. Weidle, A. Nopora, Adam Nopora, 2021, Cancer genomics & proteomics.

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity.

C. Klein, M. Dyer, K. Dabbagh, 2010, Blood.

Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer

U. Weidle, A. Nopora, Adam Nopora, 2022, AntiCancer Research.

Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models

U. Weidle, F. Birzele, A. Nopora, 2019, Cancer Genomics & Proteomics.

MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer

U. Weidle, F. Birzele, A. Nopora, 2019, Cancer Genomics & Proteomics.

microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis

U. Weidle, F. Birzele, A. Nopora, 2021, Cancer Genomics & Proteomics.

MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets

U. Weidle, A. Nopora, Adam Nopora, 2021, Cancer Genomics & Proteomics.

CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients

Fabian Birzele, E. Voss, H. Verheul, 2015, Clinical Cancer Research.

Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model

E. Voss, D. Maisel, D. Laifenfeld, 2016, PloS one.

Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

U. Weidle, F. Birzele, A. Nopora, 2018, Cancer genomics & proteomics.

MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models

U. Weidle, A. Nopora, Adam Nopora, 2022, Cancer Genomics & Proteomics.

Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.

E. Voss, D. Maisel, M. Klammer, 2012, Cancer research.

Integrated Systems and Technologies Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD 44 Antagonist

E. Voss, D. Maisel, M. Klammer, 2012 .

Bcl-2 Controls Dendritic Cell Longevity In Vivo1

T. Brocker, A. Nopora, Adam Nopora, 2002, The Journal of Immunology.

Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets

U. Weidle, A. Nopora, Adam Nopora, 2023, Cancer Genomics & Proteomics.

A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity

C. Klein, M. Venturi, M. Majety, 2013, Oncogene.

and immune effector cellmediated B-cell cytotoxicity engineering of a new type II anti-CD20 antibody with enhanced direct Increasing the efficacy of CD20 antibody therapy through the

C. Klein, M. Dyer, K. Dabbagh, 2010 .

Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.

E. Voss, D. Maisel, M. Klammer, 2012, Cancer research.

CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention

U. Weidle, Adam Nopora, 2024, Cancer Genomics & Proteomics.

Traitement du cancer à l'aide d'un anticorps anti-cdcp1 et d'un taxane

B. Bossenmaier, A. Nopora, O. Krieter, 2014 .